慢性肺病相关肺动脉高压的诊疗进展
慢性肺病相关肺动脉高压常见但认识不足,其存在与更差预后相关。近期流行病学研究提示需同时明确慢性肺病类型与肺动脉高压严重程度以指导预后判断,系统筛查与确诊流程被推荐,部分纤维化间质性肺病患者可能从治疗中获益。
要点
- 慢性肺病相关肺动脉高压常见且认识不足,存在时预后更差
- 需明确慢性肺病类型及肺动脉高压严重程度以判断自然史与预后
- 推荐对慢性肺病疑诊肺动脉高压者系统筛查与确诊
核心结论
- 慢性肺病相关肺动脉高压常见且认识不足,其存在与更差预后相关。
- 需同时明确慢性肺病类型与肺动脉高压严重程度以判断自然史和预后。
- 部分纤维化间质性肺病患者可能从肺动脉高压治疗中获益,但慢阻肺相关肺动脉高压某些治疗显示不良结局。
研究设计与样本
- 综述,总结慢性阻塞性肺疾病、间质性肺病及其他慢性肺病相关肺动脉高压的现有数据。
- 提及多项非对照研究和一项3期随机对照试验。
主要发现
- 慢性肺病相关肺动脉高压常见且认识不足,存在时与更差预后相关。
- 近期流行病学研究提示该患者群体存在异质性,需深层表型分析。
- 多项非对照研究和一项3期随机对照试验提示部分慢性肺病相关肺动脉高压患者治疗有获益,尤其是纤维化间质性肺病患者。
- 慢阻肺相关肺动脉高压等疾病中某些治疗显示不良结局。
关键数值与推荐
- 推荐对慢性肺病疑诊肺动脉高压者系统筛查与确诊。
- 鉴于肺动脉高压获批药物增多,需制定针对慢性肺病相关肺动脉高压特定表型的治疗算法。
临床怎么用
- 对慢性肺病疑诊肺动脉高压者应系统筛查与确诊。
- 治疗决策需结合慢性肺病类型与肺动脉高压严重程度进行表型区分。
- 纤维化间质性肺病相关肺动脉高压患者可能从治疗中获益,慢阻肺相关肺动脉高压某些治疗需警惕不良结局。
局限性
- 证据主要来自非对照研究,仅提及一项3期随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common and underrecognised. The presence of PH in the setting of lung disease has been consistently shown to be associated with worse outcomes. Recent epidemiological studies have advanced understanding of the heterogeneity of this patient population and shown that defining both the specific type of CLD as well as the severity of PH (i.e. deeper phenotyping) is necessary to inform natural history and prognosis. A systematic diagnostic approach to screening and confirmation of suspected PH in CLD is recommended. Numerous uncontrolled studies and one phase 3 randomised, controlled trial have suggested a benefit in treating PH in some patients with CLD, specifically those with fibrotic interstitial lung disease (ILD). However, other studies in diseases such as COPD-PH showed adverse outcomes with some therapies. Given the expanding list of approved pharmacological treatments for pulmonary arterial hypertension, developing a treatment algorithm for specific phenotypes of CLD-PH is required. This article will summarise existing data in COPD, ILD and other chronic lung diseases, and provide recommendations for classification of CLD-PH and approach to the diagnosis and management of these challenging patients.
引用
- Shlobin OA, Adir Y, Barbera JA, et al. Pulmonary hypertension associated with lung diseases. Eur Respir J. 2024. PMID: 39209469. doi:10.1183/13993003.01200-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。